Login / Signup
Excess of second tumors in denosumab-treated patients: a metabolic hypothesis.
Valeria Tovazzi
Alberto Dalla Volta
Rebecca Pedersini
Vito Amoroso
Alfredo Berruti
Published in:
Future oncology (London, England) (2019)
Keyphrases
</>
newly diagnosed
end stage renal disease
ejection fraction
prognostic factors
bone mineral density
patient reported